Table 2.
Risk factors | MDRO (n=56) | Non-MDRO (n=44) | OR (95% CI) | P |
---|---|---|---|---|
Age (years) | ||||
<50 | 20 | 12 | 1.5 | 0.36 |
50-60* | 36 | 32 | 1 | |
Sex | ||||
Male | 40 | 34 | 0.7 | 0.50 |
Female* | 16 | 10 | 1 | |
Type of diabetes | ||||
Type 1 | 6 | 12 | 0.4 | 0.12 |
Type 2* | 50 | 32 | 1 | |
Duration of diabetes (years) | ||||
<10 | 7 | 8 | 1 | 0.02 |
10-19 | 18 | 11 | 4.2 | |
>20* | 31 | 25 | 3.1 | |
Duration of ulcer (months) | ||||
≤3 | 18 | 18 | 1.4 | 0.30 |
>3 | 38 | 26 | 1 | |
Size of ulcer (cm2) | ||||
<4 | 12 | 18 | 1 | 0.03 |
>4 | 44 | 26 | 2.5 | |
Grading of ulcer | ||||
Grade 1 | 13 | 20 | 1 | 0.19 |
Grade 2 | 26 | 11 | 3.6 | |
Grade 3 | 17 | 13 | 2 | |
Complication | ||||
Nephropathy | 8 | 4 | 0.7 | 0.20 |
Neuropathy | 42 | 38 | 0.4 | |
PVD | 6 | 2 | 1 |
MROD = Multidrug-resistant organisms, CI = Confidence interval, PVD = Peripheral vascular disease, OR = Odds ratio